STOCK TITAN

Cognex Reports Third Quarter 2025 Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Cognex (NASDAQ: CGNX) reported third-quarter 2025 results: revenue $277M (+18% Y/Y; +13% excluding a one-time commercial partnership benefit). Operating margin was 20.9% and adjusted EBITDA margin was 24.9%, the highest since Q2 2023. Adjusted diluted EPS was $0.33 (+69% Y/Y); GAAP diluted EPS was $0.10. Cash and investments totaled $600M with no debt. Free cash flow was $86M (+66% Y/Y) and FCF conversion was strong. The board raised the quarterly dividend to $0.085 and repurchased $24M of stock in Q3. Q4 2025 guidance: revenue $230–$245M and adjusted EPS $0.19–$0.24.

Cognex (NASDAQ: CGNX) ha riportato i risultati del terzo trimestre 2025: ricavi $277M (+18% annuo; +13% escludendo un beneficio una tantum da una partnership commerciale). Il margine operativo è stato 20,9% e il margine EBITDA rettificato è stato 24,9%, il più alto dalla seconda metà del 2023. L'EPS diluito rettificato è stato $0.33 (+69% annuo); l'EPS diluito GAAP è stato $0.10. La cassa e gli investimenti hanno totalizzato $600M senza debiti. Il flusso di cassa libero è stato $86M (+66% annuo) e la conversione del FCF è stata forte. Il consiglio di amministrazione ha aumentato il dividendo trimestrale a $0.085 e ha riacquistato azioni per $24M nel Q3. Le previsioni per il Q4 2025 sono: ricavi di $230–$245M e EPS rettificato di $0.19–$0.24.

Cognex (NASDAQ: CGNX) informó los resultados del tercer trimestre de 2025: ingresos $277M (+18% interanual; +13% excluyendo un beneficio por una asociación comercial única). El margen operativo fue 20.9% y el margen EBITDA ajustado fue 24.9%, el más alto desde el Q2 2023. El EPS diluido ajustado fue $0.33 (+69% interanual); el EPS diluido GAAP fue $0.10. El efectivo e inversiones totalizaron $600M sin deuda. El flujo de efectivo libre fue $86M (+66% interanual) y la conversión de FCF fue fuerte. La junta elevó el dividendo trimestral a $0.085 y recompró acciones por $24M en el Q3. Guía para el Q4 2025: ingresos de $230–$245M y EPS ajustado de $0.19–$0.24.

Cognex (NASDAQ: CGNX) 2025년 3분기 실적 발표: 매출 $277M (+전년 동기 대비 18%; 단일성 상업 파트너십 이익 제외 시 +13%) 운영 마진은 20.9%이고 조정 EBITDA 마진은 24.9%로 2023년 2분기 이후 최고치입니다. 조정 희석 EPS는 $0.33 (+전년 동기 대비 69%); GAAP 희석 EPS는 $0.10였습니다. 현금 및 투자 자산은 $600M으로 부채 없음. 자유 현금 흐름은 $86M (+전년 동기 대비 66%)였고 FCF 전환도 강했습니다. 이사회는 분기 배당금을 $0.085로 인상했고 Q3에서 주식 매입 $24M을 실시했습니다. 2025년 4분기 가이던스: 매출 $230–$245M 및 조정 EPS $0.19–$0.24.

Cognex (NASDAQ: CGNX) a publié les résultats du troisième trimestre 2025 : chiffre d'affaires 277 M$ (+18 % Y/Y ; +13 % hors bénéfice ponctuel lié à un partenariat commercial). La marge opérationnelle était 20,9 % et la marge EBITDA ajustée était 24,9 %, la plus élevée depuis le 2e trimestre 2023. L'EPS dilué ajusté était $0.33 (+69 % Y/Y) ; l'EPS dilué GAAP était $0.10. La trésorerie et les investissements totalisaient $600M, sans dette. Le flux de trésorerie libre était $86M (+66 % Y/Y) et la conversion du FCF était robuste. Le conseil d'administration a relevé le dividende trimestriel à $0.085 et a racheté des actions pour $24M au T3. Prévisions pour le T4 2025 : chiffre d'affaires entre $230–$245M et EPS ajusté entre $0.19–$0.24.

Cognex (NASDAQ: CGNX) berichtete über die Ergebnisse des dritten Quartals 2025: Umsatz $277M (+18% YoY; +13% ohne einen einmaligen Vorteil aus einer kommerziellen Partnerschaft). Die operative Marge betrug 20,9% und die EBITDA-adjusted Marge betrug 24,9%, der höchste Wert seit Q2 2023. Der bereinigte verwässerte Gewinn pro Aktie betrug $0.33 (+69% YoY); GAAP verwässerter EPS betrug $0.10. Barbestände und Investitionen beliefen sich auf $600M ohne Schulden. Free Cash Flow war $86M (+66% YoY) und die FCF-Umwandlung war stark. Der Vorstand hob die vierteljährliche Dividende auf $0.085 an und zurückkaufte im Q3 Aktien im Wert von $24M. Q4 2025 Guidance: Umsatz von $230–$245M und adjustiertes EPS von $0.19–$0.24.

Cognex (NASDAQ: CGNX) أبلغت عن نتائج الربع الثالث من 2025: الإيرادات 277 مليون دولار (+18% على أساس سنوي؛ +13% باستثناء فائدة شراكة تجارية من مرة واحدة). الهامش التشغيلي كان 20.9% وهامش EBITDA المعدّل كان 24.9%، وهو الأعلى منذ الربع الثاني 2023. كان EPS المخفّف المعدّل $0.33 (+69% على أساس سنوي)؛ EPS المخفف GAAP كان $0.10. النقد والاستثمارات بلغت $600M بدون ديون. التدفق النقدي الحر كان $86M (+66% على أساس سنوي) وتحويل التدفق النقدي الحر كان قوياً. صوت المجلس بزيادة توزيعات الأرباح الربع سنوية إلى $0.085 وأعاد شراء أسهم بقيمة $24M في الربع الثالث. التوجيه للربع الرابع 2025: الإيرادات بين $230–$245M و EPS المعدّل بين $0.19–$0.24.

Cognex (NASDAQ: CGNX) 报告了2025年第三季度业绩:收入277M美元(同比增长18%;扣除一次性商业合作收益后同比增长13%)。营业利润率为20.9%,调整后的EBITDA利润率为24.9%,为自2023年第二季度以来的最高水平。调整后摊薄每股收益为$0.33(同比增长69%);GAAP摊薄每股收益为$0.10。现金及投资总额为$600M,无债务。自由现金流为$86M(同比增长66%),FCF转换率强劲。董事会将季度股息提高至$0.085,在第三季度回购股票价值$24M。2025年第四季度指引:收入为$230–$245M,调整后EPS为$0.19–$0.24

Positive
  • Revenue +18% year-over-year to $277M
  • Adjusted EBITDA +67% year-over-year to $69M
  • Adjusted diluted EPS +69% to $0.33
  • Operating margin 20.9%, up 750 basis points year-over-year
  • Cash and investments $600M with no debt
  • Free cash flow $86M, up 66% year-over-year
Negative
  • GAAP net income down 40% year-over-year to $18M
  • GAAP diluted EPS down 39% year-over-year to $0.10
  • Reported revenue includes a one-time commercial partnership benefit

Insights

Cognex reported broad revenue and margin expansion with strong cash generation, though GAAP net income fell.

Cognex grew revenue to $277 million (+18% YoY; +16% ex-FX) and delivered operating margin of 20.9% and adjusted EBITDA margin of 24.9%. Adjusted diluted EPS rose to $0.33 (+69% YoY) while free cash flow was robust at $86 million for the quarter and cash and investments totaled $600 million with no debt. These facts indicate improved unit economics driven by revenue mix and cost discipline.

Key dependencies and risks are explicit: GAAP net income declined to $18 million, adjusted metrics rely on non-GAAP adjustments, and management flags external variability (tariffs, FX, customer demand, supply chain) in its risk disclosures. Watch whether adjusted margins sustain without one-time partnership benefits and whether the company converts Q4 guidance into results.

Concrete items to monitor over the next quarter: Q4 2025 guidance of revenue $230 - $245 million, adjusted EBITDA margin guidance of 17.0% - 20.0%, and adjusted EPS guidance of $0.19 - $0.24, plus the announced dividend payable November 28, 2025 (record November 13, 2025) and quarterly cash return activity. These near-term milestones will confirm if margin expansion and cash generation are sustainable.

NATICK, Mass., Oct. 29, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the third quarter ended September 28, 2025.

Third-Quarter Financial and Operating Highlights

  • Revenue grew 18% year over year or 16% on a constant-currency basis.
  • Excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"), revenue grew 13% year over year.
  • Operating margin of 20.9%; Adjusted EBITDA margin of 24.9%, up 730 basis points year over year, and the highest level since the second quarter of 2023.
  • Net income per diluted share was $0.10; Adjusted diluted earnings per share were $0.33, an increase of 69% year over year, the fifth consecutive quarter of growth.
  • Returned $37 million to shareholders during the quarter; returned more than 100% of Free Cash Flow to shareholders over the trailing twelve-month period.
  • Announced the launch of the Solutions Experience – or SLX – product portfolio in Logistics, bringing AI-enabled Vision applications to the fast-growing Logistics market.

"I'm pleased to report Q3 was another strong quarter for Cognex," said Matt Moschner, President and CEO. "We delivered outstanding financial results, which reflect our commitment to profitable growth and disciplined execution. At the same time, we remain focused on advancing our strategic objective: to be the leading provider of AI technology for industrial machine vision. Additionally, we continued to execute our salesforce transformation, acquiring new customers in underpenetrated verticals such as Packaging, using our easy-to-use, AI-enabled products."

Dennis Fehr, CFO, added, "Our strong Q3 results reflect disciplined execution against a clear plan: driving profitable growth, maintaining cost discipline, and optimizing capital allocation. We delivered meaningful progress on operational efficiency and generated exceptional cash flow, reinforcing our ability to continue to create value for shareholders. We believe these efforts position us for sustainable margin improvement as we move through the cycle."

Financial Performance Highlights for the Third Quarter
(Dollars in millions, except per share amounts)


Three-months ended






September
28, 2025


September
28, 2025


September
29, 2024


Y/Y Change


Y/Y Change


As Reported


Excluding CP


As Reported


As Reported


Excluding CP

Revenue

$277


$264


$235


+18 %


+13 %











Operating Income

$58


$47


$32


+83 %


+50 %

% of Revenue

20.9 %


17.9 %


13.4 %


+750 bps


+450 bps











Adjusted EBITDA*

$69


$58


$41


67 %


+42 %

% of Revenue

24.9 %


22.1 %


17.6 %


+730 bps


+450 bps











Net Income per Diluted Share

$0.10


$0.06


$0.17


-39 %


-67 %











Adjusted EPS (Diluted)*

$0.33


$0.28


$0.20


+69 %


+44 %


Adjusted EBITDA and Adjusted EPS (Diluted) include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this news release.

  • Revenue was $277 million, compared with $235 million in the third quarter of 2024, an increase of 18%. Excluding the impact of foreign currency exchange (FX), revenue increased 16% compared to the prior year. The year-over-year increase in revenue was driven by growth in Logistics and strength in broader Factory Automation, particularly in Consumer Electronics and Packaging. Excluding the one-time benefit from the Commercial Partnership, revenue grew 13% year over year or 10% on a constant-currency basis.
  • Gross margin was 67.6% compared to 67.9% in the third quarter of 2024. Adjusted gross margin of 68.4% compared to 68.7% in the third quarter of 2024, a decline of 30 basis points. The year-over-year decline was primarily due to less favorable industry mix, and, to a lesser extent, the impact from tariffs, partially offset by the one-time benefit from the Commercial Partnership.
  • Operating expenses were $130 million compared to $128 million in the third quarter of 2024, an increase of 1%. Adjusted operating expenses were $125 million, consistent with the third quarter of 2024. On a constant-currency basis, Adjusted operating expenses declined 2% year over year, driven by disciplined cost management.
  • Operating income was $58 million compared to $32 million in the third quarter of 2024, an increase of 83%. Operating margin was 20.9% compared to 13.4% in the third quarter of 2024, an increase of 750 basis points. Adjusted operating margin was 23.2% compared to 15.4% in the third quarter of 2024, an increase of 780 basis points.
  • Adjusted EBITDA was $69 million compared to $41 million in the third quarter of 2024, an increase of 67%. Adjusted EBITDA margin was 24.9% compared to 17.6% in the third quarter of 2024, an increase of 730 basis points. Excluding the one-time benefit from the Commercial Partnership, Adjusted EBITDA of $58 million increased 42% year over year and Adjusted EBITDA margin of 22.1% increased 450 basis points year over year, the highest level since Q2 2023. The year-over-year expansion was driven by revenue growth and disciplined cost management.
  • Net income of $18 million compared to $30 million in the third quarter of 2024, a decrease of 40%. Adjusted net income of $56 million compared to $34 million in the third quarter of 2024, an increase of 65%.
  • Net income per diluted share was $0.10 compared to $0.17 in the third quarter of 2024, a decrease of 39%. Adjusted diluted earnings per share were $0.33 compared to $0.20 in the third quarter of 2024, an increase of 69%. Excluding the one-time benefit from the commercial partnership, Adjusted diluted earnings per share of $0.28 increased 44% year over year.

Balance Sheet and Cash Flow Highlights 

  • As of September 28, 2025, Cognex's financial position remained strong, with $600 million in cash and investments and no debt.
  • During the third quarter, Cognex generated $87 million of cash from operating activities compared to $56 million in the third quarter of 2024, an increase of 55%.
  • During the third quarter, Cognex generated Free Cash Flow (FCF) of $86 million compared to $52 million in the third quarter of 2024, an increase of 66%. Third quarter FCF conversion rate was 487% of net income and trailing twelve-month FCF conversion rate was 194% of net income. Third quarter FCF conversion rate was 153% of Adjusted net income and trailing twelve-month FCF conversion rate was 133% of Adjusted net income.
  • Cognex repurchased $24 million of its common stock and paid $13 million in dividends to shareholders in the third quarter.

Dividend

On October 29, 2025, Cognex's Board of Directors declared a quarterly cash dividend of $0.085 per share, representing an increase of $0.005 per share, or approximately 6%, over the $.08 per share dividend paid in the prior quarter. The dividend is payable on November 28, 2025, to all shareholders of record at the close of business on November 13, 2025.

Guidance

Cognex issued fourth-quarter 2025 guidance; details are summarized in the table below.

As of the date of this release, Cognex continues to expect no material impact on Adjusted Earnings per Share or Adjusted EBITDA margin from tariffs.

(Dollars in millions, except per share amounts)

Q4 2025
Guidance


Q4 2024
Results


Y/Y Change**

Revenue

$230 - $245


$230


+3 %







Adjusted EBITDA Margin1

17.0% - 20.0%


18.5 %


Flat







Adjusted Earnings Per Share (diluted)1

$0.19 - $0.24


$0.20


+7.5 %


**At the midpoint of guidance.


1Cognex has provided the forward-looking non-GAAP measures of adjusted EBITDA margin, and adjusted earnings per share (diluted), but cannot, without unreasonable effort, forecast such items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as reorganization charges, acquisition and integration charges, and amortization of acquisition-related intangible assets, all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of Cognex's control. Additionally, these items are outside of Cognex's normal business operations and not used by management to assess Cognex's operating results. Cognex believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, Cognex believes that the probable significance of such information is low. Information with respect to special items for certain historical periods is included in the section entitled "Reconciliation of Selected Items From GAAP to Non-GAAP". For these reasons, Cognex believes that the probable significance of such information is low. Information with respect to special items for certain historical periods is included in the section entitled "Reconciliation of Selected Items from GAAP to Non-GAAP." In Q4 2024 the GAAP operating margin was 13.4% and GAAP earnings per share (diluted) were $0.16.

Analyst Conference Call and Simultaneous Webcast

  • Cognex will host a conference call on October 30, 2025 at 8:30 a.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 or (201) 389-0911 if outside the United States.
  • A real-time audio broadcast of the conference call or an archived recording, together with a slide presentation, will be accessible on the Events & Presentations page of the Cognex Investor website: www.cognex.com/investor.

Forward-Looking Statements

Certain statements made in this release, as well as oral statements made by Cognex Corporation ("Cognex", "we", "us", "our", or the "Company") from time to time, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Readers can identify these forward-looking statements by our use of the words "expects," "anticipates," "estimates," "potential," "believes," "projects," "intends," "plans," "will," "may," "shall," "could," "should," "opportunity," "goal" and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance and financial targets, the impact of tariffs, customer demand and order rates and timing of related revenue, future product or revenue mix, research and development activities, sales and marketing activities, new product offerings, innovation and product development activities, customer acceptance of our products, commercial partnerships, capital expenditures, cost management activities, investments, liquidity, dividends and stock repurchases, strategic and growth plans and opportunities, acquisitions, and estimated tax benefits and expenses, changes in tax legislation, and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the technological obsolescence of current products and the inability to develop new products; (2) the impact of competitive pressures; (3) the inability to attract and retain skilled employees, effectively plan for succession including managing the change of our Chief Executive Officer, all while maintaining our unique corporate culture; (4) the failure to properly manage the distribution of products and services; (5) economic, political, and other risks associated with international sales and operations, including the impact of trade disputes, the imposition of tariffs, the economic climate in China, and the wars involving Ukraine and Israel; (6) the challenges in integrating and achieving expected results from acquired businesses; (7) uncertainty surrounding our future capital needs; (8) information security breaches and other cybersecurity threats; (9) the failure to comply with laws or regulations relating to data privacy or data protection; (10) the inability to protect our proprietary technology and intellectual property; (11) the inability to manage direct and indirect disruptions to our supply chain, which could cause delays in obtaining components for our products at reasonable prices; (12) the failure to manufacture and deliver products in a timely manner; (13) the inability to obtain, or the delay in obtaining, components for our products at reasonable prices; (14) the inability to design and manufacture high-quality products; (15) the loss of, or curtailment of purchases by, large customers in the logistics, consumer electronics, or automotive industries; (16) challenges in accurately forecasting our financial results due to seasonal and cyclical variations in customer purchasing patterns and economic and market volatility; (17) potential impairment charges with respect to our investments or acquired intangible assets; (18) exposure to additional tax liabilities, increases and fluctuations in our effective tax rate, and other tax matters; (19) fluctuations in foreign currency exchange rates and the use of derivative instruments; (20) unfavorable global economic conditions, including, without limitation, increases in interest rates, elevated inflation rates, and recession risks; (21) business disruptions from natural or man-made disasters, public health crises, or other events outside our control; (22) stock price volatility; and (23) our involvement in time-consuming and costly litigation or activist shareholder activities. The foregoing list should not be construed as exhaustive and we encourage readers to refer to the detailed discussion of risk factors included in Part I - Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as updated by our Quarterly Reports on Form 10-Q as filed with the SEC. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation to subsequently revise forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date such statements are made.

 

COGNEX CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands)


September 28,
2025


December 31, 2024


(unaudited)



ASSETS




Current assets:




Cash and cash equivalents

$           245,898


$                   186,094

Current investments, allowance for credit losses of $0 in 2025 and 2024

54,368


59,956

Accounts receivable, allowance for credit losses of $732 and $827 in 2025 and 2024,
respectively

154,612


143,359

Unbilled revenue

16,909


3,055

Inventories

143,679


157,527

Prepaid expenses and other current assets

55,453


63,376

Total current assets

670,919


613,367

Non-current investments, allowance for credit losses of $0 in 2025 and 2024

300,078


340,898

Property, plant, and equipment, net

89,868


98,445

Operating lease assets

74,182


67,326

Goodwill

392,084


384,937

Intangible assets, net

86,751


90,684

Deferred income taxes

383,611


392,166

Other assets

5,257


5,027

Total assets

$       2,002,750


$                1,992,850





LIABILITIES AND SHAREHOLDERS' EQUITY




Current liabilities:




Accounts payable

$             45,480


$                      38,046

Accrued expenses

86,708


71,760

Accrued income taxes

2,705


25,685

Deferred revenue and customer deposits

23,767


25,035

Operating lease liabilities

10,613


8,854

Total current liabilities

169,273


169,380

Non-current operating lease liabilities

68,312


61,363

Deferred income taxes

249,082


217,155

Reserve for income taxes

26,359


26,365

Other liabilities

88


1,082

Total liabilities

513,114


475,345









Shareholders' equity:




Preferred stock, $.01 par value – Authorized: 400 shares in 2025 and 2024,
respectively; no shares issued and outstanding


Common stock, $.002 par value – Authorized: 300,000 shares in 2025 and 2024,
respectively; issued and outstanding: 167,549 and 170,434 shares in 2025 and 2024,
respectively

335


341

Additional paid-in capital

1,123,134


1,090,638

Retained earnings

412,347


499,303

Accumulated other comprehensive loss, net of tax

(46,180)


(72,777)

Total shareholders' equity

1,489,636


1,517,505

Total liabilities and shareholders' equity

$       2,002,750


$                1,992,850

 

COGNEX CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)


Three-months Ended


Nine-months Ended


September 28,
2025


September 29,
2024


September 28,
2025


September 29,
2024









Revenue

$            276,892


$            234,742


$     742,021


$     684,831

Cost of revenue (1)

89,602


75,343


242,532


216,896

Gross profit

187,290


159,399


499,489


467,935

Percentage of revenue

67.6 %


67.9 %


67.3 %


68.3 %

Research, development, and engineering expenses (1)

35,081


35,210


102,910


107,277

Percentage of revenue

12.7 %


15.0 %


13.9 %


15.7 %

Selling, general, and administrative expenses (1)

94,444


92,625


269,289


276,433

Percentage of revenue

34.1 %


39.5 %


36.3 %


40.4 %

Operating income

57,765


31,564


127,290


84,225

Percentage of revenue

20.9 %


13.4 %


17.2 %


12.3 %

Foreign currency gain (loss)

840


1,221


(3,116)


1,086

Investment income

4,197


3,561


12,227


9,797

Other income (expense)

61


209


2,322


581

Income before income tax expense

62,863


36,555


138,723


95,689

Income tax expense

45,199


6,964


56,945


17,864

Net income

$              17,664


$              29,591


$       81,778


$       77,825

Percentage of revenue

6.4 %


12.6 %


11.0 %


11.4 %









Net income per weighted-average common and common-
equivalent share:








Basic

$                   0.11


$                   0.17


$            0.49


$            0.45

Diluted

$                   0.10


$                   0.17


$            0.48


$            0.45









Weighted-average common and common-equivalent shares
outstanding:








Basic

167,840


171,519


168,324


171,588

Diluted

169,323


172,753


169,507


172,733









Cash dividends per common share

$                0.080


$                0.075


$          0.240


$          0.225

























(1) Amounts include stock-based compensation expense, as follows:

Cost of revenue

$                    489


$                    442


$          1,694


$          1,460

Research, development, and engineering

3,794


3,707


11,933


11,636

Selling, general, and administrative

8,133


8,952


21,022


26,271

Total stock-based compensation expense

$              12,416


$              13,101


$       34,649


$       39,367

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures, including adjusted gross margin, adjusted operating expense, adjusted operating income and margin, adjusted EBITDA and margin, adjusted net income, adjusted earnings per share of common stock, diluted, adjusted effective tax rate, and free cash flow. Cognex defines its non-GAAP metrics as follows:

  • Adjusted gross profit and margin: Gross margin adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.
  • Adjusted operating expense: Operating expense adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.
  • Adjusted operating income and margin: Operating income adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.
  • Adjusted EBITDA and margin: Operating income adjusted for amortization of acquisition-related intangible assets and depreciation, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs and one-time discrete events.
  • Adjusted net income: Net income adjusted for amortization of acquisition-related intangible assets, as well as, if applicable, restructuring charges, reorganization charges, acquisition and integration costs, discrete tax items, tax impact on reconciling items and one-time discrete events.
  • Adjusted earnings per share of common stock, diluted: Adjusted net income divided by diluted weighted average common and common-equivalent shares.
  • Adjusted effective tax rate: Effective tax rate adjusted for discrete tax items and the net impact of the other non-GAAP adjustments.
  • Free cash flow: Cash provided by operating activities less cash for capital expenditures.
  • Free cash flow conversion rate: Free cash flow divided by adjusted net income.

Cognex may disclose results on a constant-currency basis as one measure to evaluate its performance and compare results between periods as if the exchange rates had remained constant period-over-period.

Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare results over multiple periods using the same methodology that management employs in its budgeting process, in its review of operating results, and for forecasting and planning for future periods. Cognex's definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may not publish these or similar metrics. Furthermore, these measures have certain limitations in that they do not include the impact of certain non-recurring expenses that are reflected in our consolidated statement of operations that are necessary to run our business. Thus, our non-GAAP financial measures should be considered in addition to, not as substitutes for, or in isolation from, measures prepared in accordance with GAAP.

Please see the section "Reconciliation of Selected Items from GAAP to Non-GAAP" below for more detailed information regarding non-GAAP financial measures herein, including the items reflected in our adjusted financial metrics and a description of these adjustments.

COGNEX CORPORATION
RECONCILIATION OF SELECTED ITEMS FROM GAAP TO NON-GAAP
Dollars in thousands, except per share amounts 
(Unaudited)


Three-months Ended


Nine-months Ended


September
28, 2025


September 29,
2024


September
28, 2025


September 29,
2024









Gross profit (GAAP)

$      187,290


$      159,399


$      499,489


$      467,935

Acquisition and integration costs

213


281


666


2,082

Amortization of acquisition-related intangible assets

1,379


1,640


4,099


4,457

Reorganization charges

400



486


Adjusted gross profit

$      189,282


$      161,320


$      504,740


$      474,474

GAAP gross margin

67.6 %


67.9 %


67.3 %


68.3 %

Adjusted gross margin

68.4 %


68.7 %


68.0 %


69.3 %









Operating expense (GAAP)

$      129,525


$      127,835


$      372,199


$      383,710

Acquisition and integration costs

(180)


(962)


(977)


(3,468)

Amortization of acquisition-related intangible assets

(1,260)


(1,746)


(3,846)


(4,469)

Reorganization charges

(2,966)



(4,588)


Adjusted operating expense

$      125,119


$      125,127


$      362,788


$      375,773









Operating income (GAAP)

$        57,765


$        31,564


$      127,290


$        84,225

Acquisition and integration costs

393


1,243


1,643


5,550

Amortization of acquisition-related intangible assets

2,639


3,386


7,945


8,926

Reorganization charges

3,366



5,074


Adjusted operating income

$        64,163


$        36,193


$      141,952


$        98,701

GAAP operating margin

20.9 %


13.4 %


17.2 %


12.3 %

Adjusted operating margin

23.2 %


15.4 %


19.1 %


14.4 %

Depreciation (adjusted for amounts included in Acquisition and integration costs)

4,666


5,027


14,844


15,254

Adjusted EBITDA

$        68,829


$        41,220


$      156,796


$      113,955

Adjusted EBITDA margin

24.9 %


17.6 %


21.1 %


16.6 %









Net income (GAAP)

$        17,664


$        29,591


$        81,778


$        77,825

Acquisition and integration costs

393


1,243


1,643


5,550

Amortization of acquisition-related intangible assets

2,639


3,386


7,945


8,926

Reorganization charges

3,366



5,074


Discrete tax (benefit) expense

33,650


889


33,132


3,511

Tax impact of reconciling items

(1,615)


(1,176)


(3,871)


(3,563)

Adjusted net income

$        56,097


$        33,933


$      125,701


$        92,249









Earnings per share of common stock, diluted (GAAP)

$            0.10


$            0.17


$            0.48


$            0.45

Acquisition and integration costs


0.01


0.01


0.03

Amortization of acquisition-related intangible assets

0.02


0.02


0.05


0.05

Reorganization charges

0.02



0.03


Discrete tax (benefit) expense

0.20


0.01


0.20


0.02

Tax impact of reconciling items

(0.01)


(0.01)


(0.02)


(0.02)

Adjusted earnings per share of common stock, diluted

$            0.33


$            0.20


$            0.74


$            0.53









Effective tax rate (GAAP)

71.9 %


19.1 %


41.0 %


18.7 %

Discrete tax benefit (expense)

(53.5) %


(2.4) %


(23.9) %


(3.7) %

Net impact of other reconciling items

0.6 %


1.0 %


0.9 %


1.3 %

Adjusted effective tax rate

19.0 %


17.6 %


18.0 %


16.3 %









Cash provided by operating activities (GAAP)

$        87,485


$        56,271


$      170,612


$        97,677

Capital expenditures

(1,452)


(4,399)


(6,147)


(12,970)

Free cash flow

$        86,033


$        51,872


$      164,465


$        84,707

Description of adjustments:

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Adjustments incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:

Depreciation:

  • The company incurs expense related to its normal use of property, plant and equipment.

Acquisition and integration costs:

  • The Company has incurred charges related to the purchase and integration of acquired businesses. During the periods presented, these costs were primarily related to the ongoing integration of Moritex Corporation, which the company acquired in the fourth quarter of 2023.

Amortization of acquisition-related intangible assets:

  • The Company excludes the amortization of acquired intangible assets from non-GAAP expense and income measures. These items are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions, and include the amortization of customer relationships, completed technologies, and trademarks that originated from prior acquisitions. The largest driver of intangible asset amortization was the acquisition of Moritex Corporation.

Reorganization charges:

  • The Company has incurred charges related to the reorganization of its employees. During the nine-month period ended September 28, 2025, these costs consisted primarily of severance.

Discrete tax (benefit) expense and tax impact of reconciling items:

  • Items unrelated to current period ordinary income or (loss) that generally relate to changes in tax laws, adjustments to prior period's actual liability determined upon filing tax returns, adjustments to previously recorded reserves for uncertain tax positions, establishments and adjustments of valuation allowances, stock based compensation, and adjustments to deferred tax positions.
  • We estimate the tax effect of items identified in the reconciliation by applying the statutory tax rate to the pre-tax amount.

About Cognex Corporation

For over 40 years, Cognex has been making advanced machine vision easy, paving the way for manufacturing and distribution companies to become faster, smarter, and more efficient through automation. Innovative technology in our vision sensors and systems solves critical manufacturing and distribution challenges, providing unparalleled performance for industries from automotive to consumer electronics to packaged goods.

Cognex makes these tools more capable and easier to deploy thanks to a longstanding focus on AI, helping factories and warehouses improve quality and maximize efficiency without needing highly technical expertise. We are headquartered near Boston, USA, with locations in over 30 countries and more than 30,000 customers worldwide. Learn more at cognex.com.

Investor Contacts:
Greer Aviv – Head of Investor Relations
Jordan Bertier – Senior Manager, Investor Relations
Cognex Corporation
ir@cognex.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cognex-reports-third-quarter-2025-results-302598849.html

SOURCE Cognex Corporation

FAQ

What were Cognex (CGNX) third-quarter 2025 revenues and growth rates?

Cognex reported $277M revenue in Q3 2025, up 18% Y/Y and 13% Y/Y excluding a one-time commercial partnership benefit.

How did Cognex (CGNX) profitability perform in Q3 2025?

Operating margin was 20.9% and adjusted EBITDA margin was 24.9%, with adjusted diluted EPS of $0.33 (+69% Y/Y).

What is Cognex's (CGNX) cash position and debt status as of Q3 2025?

Cognex held $600M in cash and investments and reported no debt as of September 28, 2025.

Did Cognex (CGNX) return capital to shareholders in Q3 2025?

Yes—Cognex repurchased $24M of stock, paid $13M in dividends, and the board raised the quarterly dividend to $0.085.

How did one-time items affect Cognex's (CGNX) Q3 2025 results?

Excluding a one-time commercial partnership benefit, revenue growth was 13% Y/Y and adjusted EPS would be $0.28.

What guidance did Cognex (CGNX) give for Q4 2025?

Q4 2025 guidance is $230–$245M revenue and adjusted diluted EPS of $0.19–$0.24; midpoint revenue implies ~+3% Y/Y.
Cognex Corp

NASDAQ:CGNX

CGNX Rankings

CGNX Latest News

CGNX Latest SEC Filings

CGNX Stock Data

7.97B
167.07M
0.28%
101.09%
3.63%
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
Link
United States
NATICK